Creteil, France.
Lille, France.
Aliment Pharmacol Ther. 2021 May;53(10):1098-1107. doi: 10.1111/apt.16353. Epub 2021 Apr 5.
The burden of inflammatory bowel disease (IBD) is rising worldwide. The goal of IBD treatment is to achieve clinical and endoscopic remission but also prevent disability.
To identify the predictive factors of disability in a large population of patients with IBD.
We conducted a cross-sectional survey in 42 tertiary centres in France and Belgium. A self-administered questionnaire was designed to explore patients and their IBD characteristics. IBD-disk is a validated tool to measure disability in patients with IBD. The IBD-disk score was then calculated for each patient. Based on a previous study, an overall IBD-disk score ≥40 was associated with moderate-to-severe disability.
Among the 2011 patients, 1700 were analysed, including 746 (44%) in self-reported clinical remission and 752 (44.2%) declaring clinical activity. The patient global assessment of global remission was missing in 200 (11.8%) of 1700 patients. Moderate-to-severe disability was significantly increased in patients with BMI >25 kg/m (OR = 1.66; 95% CI [1.29-2.14]), in those having perception of need for a psychotherapist (OR = 2.24; 95% CI [1.79-3.05]) and social worker (OR = 1.54; 95% CI [1.08-2.21]). Conversely, male gender (OR = 0.83; 95% CI [0.69-0.99]), ulcerative colitis (OR = 0.69; 95% CI [0.53-0.92]), self-reported clinical remission (OR = 0.59; 95% CI [0.46-0.77]) and employed or student occupational status (OR = 0.69; 95% CI [0.52-0.92]) were inversely correlated with disability. Overall, 257 (34.5%) patients who declared being in clinical remission had disability.
Determinants of IBD-related disability include IBD-related factors but also psychological and social factors. This highlights the importance of a multidisciplinary team in the management of patients with IBD.
炎症性肠病(IBD)的负担在全球范围内不断增加。IBD 治疗的目标是实现临床和内镜缓解,但也要预防残疾。
确定在大量 IBD 患者中残疾的预测因素。
我们在法国和比利时的 42 个三级中心进行了一项横断面调查。设计了一份自我管理问卷,以探讨患者及其 IBD 特征。IBD-disk 是一种用于衡量 IBD 患者残疾的经过验证的工具。然后为每位患者计算 IBD-disk 评分。基于先前的研究,总分≥40 分与中重度残疾相关。
在 2011 名患者中,分析了 1700 名患者,其中 746 名(44%)自我报告处于临床缓解期,752 名(44.2%)报告存在临床活动。在 1700 名患者中,有 200 名(11.8%)患者缺失对整体疾病缓解的患者全球评估。BMI>25kg/m2 的患者中,中重度残疾显著增加(OR=1.66;95%CI[1.29-2.14]),有心理治疗师(OR=2.24;95%CI[1.79-3.05])和社工(OR=1.54;95%CI[1.08-2.21])需求感知的患者中也显著增加。相反,男性(OR=0.83;95%CI[0.69-0.99])、溃疡性结肠炎(OR=0.69;95%CI[0.53-0.92])、自我报告临床缓解(OR=0.59;95%CI[0.46-0.77])和就业或学生职业状态(OR=0.69;95%CI[0.52-0.92])与残疾呈负相关。总体而言,257 名(34.5%)报告处于临床缓解期的患者存在残疾。
IBD 相关残疾的决定因素包括 IBD 相关因素,还包括心理和社会因素。这突显了多学科团队在 IBD 患者管理中的重要性。